PMID- 37688178 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230912 IS - 2073-4360 (Electronic) IS - 2073-4360 (Linking) VI - 15 IP - 17 DP - 2023 Aug 26 TI - Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets. LID - 10.3390/polym15173554 [doi] LID - 3554 AB - Three-dimensional printing has revolutionized drug manufacturing and has provided a solution to the limitations associated with the conventional manufacturing method by designing complex drug delivery systems with customized drug release profiles for personalized therapies. The present investigation aims to design a gastric floating tablet with prolonged gastric floating time and sustained drug release profile. In the present study, a gastro retentive floating device (GRFD) was designed and fabricated using a fused deposition modelling (FDM)-based 3D printing technique. This device acts as a multifunctional dosage form exhibiting prolonged gastric retention time and sustained drug release profile with improved oral bioavailability in the upper gastrointestinal tract. Commercial polyvinyl alcohol (PVA) and polylactic acid (PLA) filaments were used to design GRFD, which was comprised of dual compartments. The outer sealed compartment acts as an air-filled chamber that imparts buoyancy to the device and the inner compartment is filled with a commercial propranolol hydrochloride immediate-release tablet. The device is designed as a round-shaped shell with a central opening of varying size (1 mm, 2 mm, 3 mm, and 4 mm), which acts as a drug release window. Scanning electron microscope (SEM) images were used to determine morphological characterization. The in vitro buoyancy and drug release were evaluated using the USP type II dissolution apparatus. All the designed GRFDs exhibit good floating ability and sustained drug release profiles. GRFDs fabricated using PLA filament show maximum buoyancy (>24 h) and sustained drug release for up to 10 h. The floating ability and drug release from the developed devices were governed by the drug release window opening size and the filament material affinity towards the gastric fluid. The designed GRFDs show great prospects in modifying the drug release characteristics and could be applied to any conventional immediate-release product. FAU - Alqahtani, Abdulsalam A AU - Alqahtani AA AUID- ORCID: 0000-0001-7243-8042 AD - Department of Pharmaceutics, College of Pharmacy, Najran University, Najran 11001, Saudi Arabia. FAU - Mohammed, Abdul Aleem AU - Mohammed AA AUID- ORCID: 0000-0003-2601-7962 AD - Department of Pharmaceutics, College of Pharmacy, Najran University, Najran 11001, Saudi Arabia. FAU - Fatima, Farhat AU - Fatima F AUID- ORCID: 0000-0002-5783-9363 AD - Department of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia. FAU - Ahmed, Mohammed Muqtader AU - Ahmed MM AUID- ORCID: 0000-0001-6911-0652 AD - Department of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia. LA - eng GR - NU/DRP/MRC/12/33/Najran University/ PT - Journal Article DEP - 20230826 PL - Switzerland TA - Polymers (Basel) JT - Polymers JID - 101545357 PMC - PMC10490505 OTO - NOTNLM OT - 3D printing OT - PLA OT - PVA OT - dissolution kinetics OT - fused deposition modelling OT - gastro-retentive floating device COIS- The authors declare no conflict of interest. EDAT- 2023/09/09 11:46 MHDA- 2023/09/09 11:47 PMCR- 2023/08/26 CRDT- 2023/09/09 01:24 PHST- 2023/06/30 00:00 [received] PHST- 2023/08/09 00:00 [revised] PHST- 2023/08/23 00:00 [accepted] PHST- 2023/09/09 11:47 [medline] PHST- 2023/09/09 11:46 [pubmed] PHST- 2023/09/09 01:24 [entrez] PHST- 2023/08/26 00:00 [pmc-release] AID - polym15173554 [pii] AID - polymers-15-03554 [pii] AID - 10.3390/polym15173554 [doi] PST - epublish SO - Polymers (Basel). 2023 Aug 26;15(17):3554. doi: 10.3390/polym15173554.